Cited by 618Probiotics and Fermented FoodsGut microbiota and healthInfant Nutrition and Health

The DOI matches its Crossref record; 121 of the 125 references it cites were found in a registry or an index.

Review article: bifidobacteria as probiotic agents – physiological effects and clinical benefits

Open access
PICARD, C., FIORAMONTI, J., FRANCOIS, A., ROBINSON, T., NEANT, F., MATUCHANSKY, C.·2005·Alimentary Pharmacology & Therapeutics

Abstract

Summary: Bifidobacteria, naturally present in the dominant colonic microbiota, represent up to 25% of the cultivable faecal bacteria in adults and 80% in infants. As probiotic agents, bifidobacteria have been studied for their efficacy in the prevention and treatment of a broad spectrum of animal and/or human gastrointestinal disorders, such as colonic transit disorders, intestinal infections, and colonic adenomas and cancer. The aim of this review is to focus on the gastrointestinal effects of bifidobacteria as probiotic agents in animal models and man. The traditional use of bifidobacteria in fermented dairy products and the GRAS (‘Generally Recognised As Safe’) status of certain strains attest to their safety. Some strains, especially Bifidobacterium animalis strain DN‐173 010 which has long been used in fermented dairy products, show high gastrointestinal survival capacity and exhibit probiotic properties in the colon. Bifidobacteria are able to prevent or alleviate infectious diarrhoea through their effects on the immune system and resistance to colonization by pathogens. There is some experimental evidence that certain bifidobacteria may actually protect the host from carcinogenic activity of intestinal flora. Bifidobacteria may exert protective intestinal actions through various mechanisms, and represent promising advances in the fields of prophylaxis and therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2005.02615.x

Cites

121 of 121 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 125 references

Research works printed but not linked: 4

  1. 10.1079/BJN/2002530 · DOI
  2. European commission (Health and Consumer protection directorate‐general), Qualified Presumption of Safety. On a Generic Approach to the Safety Assessment of micro‐organisms Used in Feed/food and Feed/food Production
  3. FAO/WHO, 2001, Report of a Joint FAO/WHO Expert Group. Health and Nutritional Properties of Probiotics in Food Including Powder milk with Live Lactic Acid Bacteria
  4. 10.1097/00005176-200403000-00011 · DOI

Cited by

Sorted by citations

Items 101–200 of 616

Metadata

Authors
PICARD, C., FIORAMONTI, J., FRANCOIS, A., ROBINSON, T., NEANT, F., & MATUCHANSKY, C.
Affiliations
  • Danone (France) (FR)
  • Institut National de la Recherche Agronomique (FR)
  • Hôpital Lariboisière (FR)
Corresponding author
PICARD, C.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2005-09
Volume
22
Issue
6
Pages
495-512
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2168595823
Cited by
618
References
125
Citations by year
2026: 7 · 2025: 21 · 2024: 31 · 2023: 36 · 2022: 45 · 2021: 40 · 2020: 32 · 2019: 33 · 2018: 39 · 2017: 39 · 2016: 33 · 2015: 22 · 2014: 40 · 2013: 27 · 2012: 26
FWCI
2.65
Type
journal article
Language
en
Open access
Locations
  • Alimentary Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
Keywords
Bifidobacterium, probiotics, fermented dairy products, gastrointestinal diseases, infectious diarrhea, immunomodulation, gut microbiota, probiotic safety, GRAS status, gastrointestinal survival
MeSH terms
Adult, Bifidobacterium, Female, Gastrointestinal Diseases, Gastrointestinal Transit, Humans, Infant, Male, Neoplasms, Probiotics, Gastrointestinal Tract, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review